Software Healthcare Sector

Matinas BioPharma Holdings

Market Cap: US$2.9m

A clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology.

Enzolytics

Market Cap: US$2.9m

A drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.

Grey Matters Health

Market Cap: CA$4.0m

Operates as a clinical stage pharmaceutical development company in Canada, the United States, and Australia.

ASEP Medical Holdings

Market Cap: CA$4.0m

Engages in the acquisition of research and development assets, technologies, and businesses in the area of life sciences and medical diagnostics.

Herbal Dispatch

Market Cap: CA$3.9m

Engages in the sale of cannabis and cannabis related products in Canada and internationally.

9 Meters Biopharma

Market Cap: US$2.8m

9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders in North America.

Vaccinex

Market Cap: US$2.8m

A clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders.

bioAffinity Technologies

Market Cap: US$2.8m

Engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.

ValiRx

Market Cap: UK£2.0m

Engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom.

Medical Marijuana

Market Cap: US$2.8m

An investment holding company, operates in the cannabinoid-based nutraceutical industry.

Sonendo

Market Cap: US$2.8m

A commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada.

Emmaus Life Sciences

Market Cap: US$2.7m

A commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally.

Universal Biosensors

Market Cap: AU$4.2m

Through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally.

Bioxytran

Market Cap: US$2.7m

A clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address viral infections, glycovirology, and oxygen delivery, hypoxia and degenerative diseases in humans.

EHAVE

Market Cap: US$2.7m

A healthcare company, develops medical psychedelics and mental health data platform that integrates with proprietary and third-party assessment and therapeutic digital applications in Canada.

StrainsforPains

Market Cap: US$2.7m

Operates as a health and wellness company that specializes in data technology that develops and sells CBD/THC products.

CASI Pharmaceuticals

Market Cap: US$2.6m

A biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People’s Republic of China, the United States, and internationally.

CS Diagnostics

Market Cap: US$2.6m

Engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally.

Lifeline Biotechnologies

Market Cap: US$2.6m

Operates as a medical technology company in the United States.

Standard Dental Labs

Market Cap: US$2.6m

A dental laboratory company, manufactures dental products in Florida.

Propanc Biopharma

Market Cap: US$2.6m

A development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia.

AccuStem Sciences

Market Cap: US$2.6m

A clinical stage diagnostics company, focuses on developing and commercializing a suite of novel genomic tests for oncology care.

Global Health

Market Cap: AU$3.6m

Provides digital health solutions for the healthcare industry in Australia.

Clearmind Medicine

Market Cap: US$2.5m

A clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems.

Onconetix

Market Cap: US$2.5m

A biotechnology company, focuses on the research, development, and commercialization of solutions for men’s health and oncology in the United States, the European Union, and Non-European Union.

BPH Global

Market Cap: AU$3.5m

Engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia.

Aleen

Market Cap: US$2.5m

A digital health startup company, develops an artificial intelligence based online health diagnostics platform for assessing preliminary health condition and symptoms.

Freedom Care Group Holdings

Market Cap: AU$4.0m

Provides care and support services to individuals with disabilities in Australia.

AJ1G

Market Cap: US$2.5m

Operates as a diversified cannabis holding company in Florida.

NuGen Medical Devices

Market Cap: CA$3.4m

A specialty medical device company, engages in developing and commercializing novel drug delivery technologies in Europe, Asia, and internationally.

Quest PharmaTech

Market Cap: CA$3.4m

A pharmaceutical company, develops targeted cancer therapies in Canada.

Stem Cell Authority

Market Cap: US$2.4m

A technology development company, focuses on the collection and cryogenic preservation of stem cells.

Stella Diagnostics

Market Cap: US$2.4m

A research diagnostics company, engages in developing molecular diagnostics tools and new drug targets for esophageal diseases.

Therma Bright

Market Cap: CA$3.4m

Acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace.

Incanthera

Market Cap: UK£1.7m

A dermatology and oncology therapeutics company, engages in the dermatological formulation and delivery technologies for various indications.

Agape ATP

Market Cap: US$2.4m

An investment holding company, supplies health and wellness products and health solution advisory services in Malaysia.